Evidence map›Paper›PMID 17005759›Full record

ArticleJournal of clinical microbiology2006

Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis.

Philip Supply, Caroline Allix, Sarah Lesjean, Mara Cardoso-Oelemann, Sabine Rüsch-Gerdes, Eve Willery, Evgueni Savine, Petra de Haas, Henk van Deutekom, Solvig Roring and 13 more

Abstract readComparative Study
In one paragraph

Article in Journal of clinical microbiology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 658 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
658citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

658 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Microorganisms · 2026
    Article
  8. A Case of Transmission of Bedaquiline- and Linezolid-Resistant Tuberculosis.International journal of molecular sciences · 2026
    Article
  9. Molecular Characterization ofHealth science reports · 2026
    Article
  10. Article
  11. Understanding recurrence inJournal of clinical microbiology · 2026
    Review
  12. Insight into the genetic diversity ofMicrobiology spectrum · 2026
    Article
  13. Long-term refined genomic analysis of tuberculosis clusters to distinguish between ongoing transmission, reactivations or diagnostic delays, Almería, Spain, 2003 to 2024.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  14. Article
  15. Genetic Diversity and Molecular Epidemiology ofPathogens (Basel, Switzerland) · 2026
    Article
  16. Article
  17. Article
  18. Evaluation of thermal desorption-electrospray ionization mass spectrometry for characterization ofJournal of mass spectrometry and advances in the clinical lab · 2025
    Article
  19. Article
  20. Article

598 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Philip SupplyINSERM U629, Institut Pasteur de Lille, 1, rue du Prof. Calmette, F-59019 Lille Cedex, France. Philip.Supply@pasteur-lille.fr
Caroline Allix
Sarah Lesjean
Mara Cardoso-Oelemann
Sabine Rüsch-Gerdes
Eve Willery
Evgueni Savine
Petra de Haas
Henk van Deutekom
Solvig Roring
Pablo Bifani
Natalia Kurepina
Barry Kreiswirth
Christophe Sola
Nalin Rastogi
Vincent Vatin
Maria Cristina Gutierrez
Maryse Fauville
Stefan Niemann
Robin Skuce
Kristin Kremer
Camille Locht
Dick van Soolingen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular typing based on 12 loci containing variable numbers of tandem repeats of mycobacterial interspersed repetitive units (MIRU-VNTRs) has been adopted in combination with spoligotyping as the basis for large-scale, high-throughput genotyping of Mycobacterium tuberculosis. However, even the combination of these two methods is still less discriminatory than IS6110 fingerprinting. Here, we define an optimized set of MIRU-VNTR loci with a significantly higher discriminatory power. The resolution and the stability/robustness of 29 loci were analyzed, using a total of 824 tubercle bacillus isolates, including representatives of the main lineages identified worldwide so far. Five loci were excluded for lack of robustness and/or stability in serial isolates or isolates from epidemiologically linked patients. The use of the 24 remaining loci increased the number of types by 40%--and by 23% in combination with spoligotyping--among isolates from cosmopolitan origins, compared to those obtained with the original set of 12 loci. Consequently, the clustering rate was decreased by fourfold--by threefold in combination with spoligotyping--under the same conditions. A discriminatory subset of 15 loci with the highest evolutionary rates was then defined that concentrated 96% of the total resolution obtained with the full 24-locus set. Its predictive value for evaluating M. tuberculosis transmission was found to be equal to that of IS6110 restriction fragment length polymorphism typing, as shown in a companion population-based study. This 15-locus system is therefore proposed as the new standard for routine epidemiological discrimination of M. tuberculosis isolates and the 24-locus system as a high-resolution tool for phylogenetic studies.

Indexed as

Interspersed Repetitive SequencesMinisatellite RepeatsBacterial Typing TechniquesCluster AnalysisDNA, BacterialDNA FingerprintingDNA Transposable ElementsGenotypeHumansMolecular EpidemiologyMycobacterium tuberculosisPhylogenyPolymorphism, Restriction Fragment LengthPredictive Value of TestsReproducibility of ResultsTuberculosisDNA, BacterialDNA Transposable Elements

Identifiers

PMID17005759
PMCPMC1698431

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.